VNA 932
Alternative Names: WAY VNA 932Latest Information Update: 27 Mar 2002
At a glance
- Originator Wyeth
- Class
- Mechanism of Action Vasopressin V2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes insipidus; Urinary incontinence
Most Recent Events
- 27 Mar 2002 American Home Products and its subsidiaries Wyeth-Ayerst and Wyeth Lederle are both now called Wyeth
- 21 Mar 2002 Discontinued - Phase-I for Diabetes insipidus in USA (PO)
- 21 Mar 2002 Discontinued - Preclinical for Urinary incontinence in USA (PO)